Literature DB >> 31972002

Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma.

Regina Wan Ju Wong1, Tze King Tan1, Stella Amanda1, Phuong Cao Thi Ngoc1, Wei Zhong Leong1, Shi Hao Tan1, Kaori Asamitsu2, Yurina Hibi2, Ryuzo Ueda3, Takashi Okamoto2, Takashi Ishida4, Shinsuke Iida5, Takaomi Sanda1,5,6.   

Abstract

Adult T-cell leukemia/lymphoma (ATL) is a highly aggressive hematological malignancy derived from mature CD4+ T-lymphocytes. Here, we demonstrate the transcriptional regulatory network driven by 2 oncogenic transcription factors, IRF4 and NF-κB, in ATL cells. Gene expression profiling of primary ATL samples demonstrated that the IRF4 gene was more highly expressed in ATL cells than in normal T cells. Chromatin immunoprecipitation sequencing analysis revealed that IRF4-bound regions were more frequently found in super-enhancers than in typical enhancers. NF-κB was found to co-occupy IRF4-bound regulatory elements and formed a coherent feed-forward loop to coordinately regulate genes involved in T-cell functions and development. Importantly, IRF4 and NF-κB regulated several cancer genes associated with super-enhancers in ATL cells, including MYC, CCR4, and BIRC3. Genetic inhibition of BIRC3 induced growth inhibition in ATL cells, implicating its role as a critical effector molecule downstream of the IRF4-NF-κB transcriptional network.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31972002     DOI: 10.1182/blood.2019002639

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  The molecular basis for the development of adult T-cell leukemia/lymphoma in patients with an IRF4K59R mutation.

Authors:  Srinivasan Sundararaj; Sandali Seneviratne; Simon J Williams; Anselm Enders; Marco G Casarotto
Journal:  Protein Sci       Date:  2022-02-15       Impact factor: 6.725

2.  Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia.

Authors:  Jolynn Zu Lin Ong; Rui Yokomori; Regina Wan Ju Wong; Tze King Tan; Ryuzo Ueda; Takashi Ishida; Shinsuke Iida; Takaomi Sanda
Journal:  Leukemia       Date:  2022-07-30       Impact factor: 12.883

3.  Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.

Authors:  Helena Van Damme; Bruno Dombrecht; Máté Kiss; Heleen Roose; Elizabeth Allen; Eva Van Overmeire; Daliya Kancheva; Liesbet Martens; Aleksandar Murgaski; Pauline Madeleine Rachel Bardet; Gillian Blancke; Maude Jans; Evangelia Bolli; Maria Solange Martins; Yvon Elkrim; James Dooley; Louis Boon; Julia Katharina Schwarze; Frank Tacke; Kiavash Movahedi; Niels Vandamme; Bart Neyns; Sebahat Ocak; Isabelle Scheyltjens; Lars Vereecke; Frank Aboubakar Nana; Pascal Merchiers; Damya Laoui; Jo Agnes Van Ginderachter
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

4.  Loss of interleukin-10 activates innate immunity to eradicate adult T-cell leukemia-initiating cells.

Authors:  Hiba El Hajj; Rita Hleihel; Marwan El Sabban; Julie Bruneau; Ghazi Zaatari; Morgane Cheminant; Ambroise Marçais; Abdou Akkouche; Hideki Hasegawa; William Hall; Hugues De Thé; Olivier Hermine; Ali Bazarbachi
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

Review 5.  Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity.

Authors:  Zhongyi Jiang; Haitao Zhu; Pusen Wang; Weitao Que; Lin Zhong; Xiao-Kang Li; Futian Du
Journal:  MedComm (2020)       Date:  2022-04-21

6.  Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.

Authors:  Koen Debackere; Lukas Marcelis; Sofie Demeyer; Marlies Vanden Bempt; Nicole Mentens; Olga Gielen; Kris Jacobs; Michael Broux; Gregor Verhoef; Lucienne Michaux; Carlos Graux; Iwona Wlodarska; Philippe Gaulard; Laurence de Leval; Thomas Tousseyn; Jan Cools; Daan Dierickx
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

7.  Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.

Authors:  Xuanzong Li; Shujun Zhai; Jianbo Zhang; Dai Zhang; Shijiang Wang; Linlin Wang; Jinming Yu
Journal:  Front Oncol       Date:  2021-06-14       Impact factor: 6.244

8.  Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma.

Authors:  Daniel A Rauch; John C Harding; Lee Ratner; Samuel A Wickline; Hua Pan
Journal:  Nanomaterials (Basel)       Date:  2021-06-16       Impact factor: 5.076

9.  Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma.

Authors:  Daniel A Rauch; Sydney L Olson; John C Harding; Hemalatha Sundaramoorthi; Youngsoo Kim; Tianyuan Zhou; A Robert MacLeod; Grant Challen; Lee Ratner
Journal:  Retrovirology       Date:  2020-08-28       Impact factor: 4.602

10.  Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.

Authors:  Hanhao Zheng; Changhao Chen; Yuming Luo; Min Yu; Wang He; Mingjie An; Bowen Gao; Yao Kong; Yiyao Ya; Yan Lin; Yuting Li; Keji Xie; Jian Huang; Tianxin Lin
Journal:  Clin Transl Med       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.